In this Friday’s Rethinking Clinical Trials Grand Rounds, Kenneth Kehl of the Dana-Farber Cancer Institute will present “Clinical Trial Notifications Triggered by Artificial Intelligence–Detected Cancer Progression.”
The Grand Rounds session will be held on Friday, August 1, 2025, at 1:00 pm eastern.
Kehl is a physician and associate director of research at the Dana-Farber Cancer Institute and an assistant professor of medicine at Harvard Medical School.